Functional systems scores and expanded disability status scale score evaluations in the ultimate I and II studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis
MULTIPLE SCLEROSIS JOURNAL(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined